These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20292230)

  • 1. Shigella carriers with special reference to their therapy, including the use of streptomycin.
    VAN GELDER DW; DAINES WP; FISCHER GL
    Am J Trop Med Hyg; 1947 Mar; 27(2):225-31. PubMed ID: 20292230
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriologic studies in an epidemic of bacillary dysentery in Korea; serotypes of Shigella and Salmonella recovered and bacteriologic response to sulfadiazine, chloramphenicol, terramycin, aureomycin and streptomycin.
    ZIMMERMAN LE; COOPER M; GRABER CD
    Am J Clin Pathol; 1952 Jun; 22(6):549-57. PubMed ID: 14933330
    [No Abstract]   [Full Text] [Related]  

  • 3. AETIOLOGY OF DYSENTERY AND RESPONSE OF CASES OF BACILLARY DYSENTERY TO COMMONLY USED DRUGS IN A SERIES OF CASES ADMITTED TO A FACTORY HOSPITAL IN KANPUR.
    NATH K; AGRAWAL BL; AGRAWAL SN; SHRINIWAS ; BAGCHI AK
    J Assoc Physicians India; 1964 Jul; 12():523-9. PubMed ID: 14184096
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of shigella enteritis with oral streptomycin; a report of 34 cases.
    ROSS S; BURKE FG
    J Am Med Assoc; 1949 Sep; 141(3):183-5. PubMed ID: 18139543
    [No Abstract]   [Full Text] [Related]  

  • 5. [PATTERN OF DRUG RESISTANCE OF SHIGELLA AND EPIDEMIOLOGIC PROBLEMS].
    SAITO M
    J Antibiot B; 1964 Jun; 17():109-12. PubMed ID: 14201521
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDIES ON THE MECHANISM OF DEVELOPMENT AND IMMUNITY IN EXPERIMENTAL DYSENTERY].
    ASAHI T; GODA A; KAZUNO Y; USHIBA D; SASAKI S; UJIIE A; KISHIMOTO Y; WATANABE T; KOBARI I; SEKIGUCHI T
    Nihon Densenbyo Gakkai Zasshi; 1963 Oct; 37():249-61. PubMed ID: 14092816
    [No Abstract]   [Full Text] [Related]  

  • 7. REPLACEMENT COLIFORM FLORA IN CARRIERS OF INTESTINAL PATHOGENS.
    STEWART GT; HOLT RJ; COLES HM; BHAT KM
    J Hyg (Lond); 1964 Mar; 62(1):39-44. PubMed ID: 14128318
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of streptomycin resistance of the shigellae.
    KLEIN M; KIMMELMAN LJ
    J Bacteriol; 1946 May; 51():581. PubMed ID: 20987021
    [No Abstract]   [Full Text] [Related]  

  • 9. INVESTIGATION OF DRUG SENSITIVITY IN SHIGELLA AND ITS CORRELATION WITH "IN VIVO" SENSITIVITY.
    FISCHLER E; WALLIS K
    Ann Paediatr; 1963; 201():49-63. PubMed ID: 14043574
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON SOME CURRENT PROBLEMS IN MICROBIOLOGICAL DIAGNOSIS, EPIDEMIOLOGY, THERAPY AND PREVENTION OF BACILLARY DYSENTERY. V. STATE OF SHIGELLA SENSITIVITY TO ANTIBIOTICS].
    ALDOVA E; JELINEK J
    Cesk Epidemiol Mikrobiol Imunol; 1964 Mar; 13():96-101. PubMed ID: 14142629
    [No Abstract]   [Full Text] [Related]  

  • 11. [The importance of drug associations in the treatment of diarrhea].
    JADIN J; WERY M
    Ann Soc Belg Med Trop (1920); 1962 Oct; 42():703-42. PubMed ID: 13964418
    [No Abstract]   [Full Text] [Related]  

  • 12. [MULTIPLE INFECTIOUS RESISTANCE TO ANTIBIOTICS AND SULFONAMIDES IN DYSENTERY BACTERIA].
    LEBEK G; SCHMIEDEL A
    Dtsch Med Wochenschr; 1964 Dec; 89():2464-7. PubMed ID: 14223826
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.
    FRETER R
    J Exp Med; 1956 Sep; 104(3):411-8. PubMed ID: 13357693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Shigella keratoconjunctivitis reaction in guinea pig in the study of streptomycin and chlortetracycline effects].
    MANOLOV DG; GESHEVA RL; TOSHKOV AS
    Antibiotiki (Mosc); 1958; 3(5):72-5. PubMed ID: 24545106
    [No Abstract]   [Full Text] [Related]  

  • 15. [Systematic and serological diagnosis of the bacillary dysenteria with special reference to Shigella-sera of the Paul Ehrlich institution].
    HEYMANN G
    Arztl Wochensch; 1952 Jul; 7(30):698-700. PubMed ID: 12976276
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on experimental Shigella infection. 2. On the appearance of resistant organisms in shigella infections of mice wth the aid of antibiotic administration].
    IWATA K; MLOTE H
    Nihon Saikingaku Zasshi; 1962 Aug; 17():702-5. PubMed ID: 13964249
    [No Abstract]   [Full Text] [Related]  

  • 17. Aureomycin; a new antibiotic with a special reference to its action on Shigella (dysenteric group of organisms).
    SUBBA RAO KV
    Antiseptic; 1951 Oct; 48(10):789-806. PubMed ID: 14878433
    [No Abstract]   [Full Text] [Related]  

  • 18. [A STUDY OF THE ANTIBIOTIC SENSITIVITY OF CULTURES OF DYSENTERY BACILLI AND ENTEROPATHOGENIC COLIBACILLI CONDUCTED IN A SANITARY EPIDEMIOLOGICAL LABORATORY IN 1961].
    SHEMIAKINA AA; STEPANOVA SV
    Antibiotiki; 1964 Feb; 9():165-7. PubMed ID: 14186716
    [No Abstract]   [Full Text] [Related]  

  • 19. Shigellosis in custodial institutions. V. Effect of intervention with streptomycin-dependent Shigella sonnei vaccine in an institution with endemic disease.
    Levine MM; Gangarosa EJ; Barrow WB; Weiss CF
    Am J Epidemiol; 1976 Jul; 104(1):88-92. PubMed ID: 779465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
    Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
    Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.